NCT01306656View on ClinicalTrials.gov

Vitamin D Repletion in Primary Hyperparathyroidism

PHASE4CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Primary HyperparathyroidismVitamin D Deficiency
Interventions
DRUG

10,000 IU Vitamin D3

"Month 1: 20,000 IU vitamin D3 once a week~Months 2-6: 10,000 IU vitamin D3 once a week"

OTHER

Placebo

"Month 1: Placebo once a week~Months 2-6: Placebo once a week"

DIETARY_SUPPLEMENT

Vitamin D

Daily multivitamin with 400 IU vitamin D.

Trial Locations (1)

10032

Columbia University Medical Center, New York

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Columbia University

OTHER

NCT01306656 - Vitamin D Repletion in Primary Hyperparathyroidism | Biotech Hunter | Biotech Hunter